Why This Newsletter

There will be 420 overall updates in the newly released Current Procedural Terminology (CPT®) 2025 code set. The 420 updates include 270 new CPT codes, 112 deletions, and 38 revisions.

****

Category III CPT codes for emerging medical and surgical services accounted for 30% of the 270 new CPT codes created. Seven new CPT III codes were established for services driven by augmented intelligence (AI), often referred to as “artificial intelligence.”

The 2025 CPT code set expanded into new area of medicine with proprietary laboratory analyses assigned the largest proportion of new codes, 37%, mostly for novel genetic testing.

Revisions included remote therapeutic monitoring services, which involve the monitoring of data related to signs, symptoms and functions of a therapeutic response. Updates were made to CPT’s general surgery section to reflect novel approaches in skin grafts for wound care and the recovery and advancements in surgical techniques for the elimination of tumors within the abdomen.

For additional information about the CPT code set click here https://rowinskigroup.com/key-reimbursement-stakeholders-resources . Scroll down to Coding Organizations and open the Current Procedural Terminal (CPT) Codes portal.

® CPT Current Procedural Terminology is registered with the American Medical Association (AMA)

****

About Rowinski Group

Founded in 2004, Rowinski Group LLC is a reimbursement and healthcare payer data analytics consultancy for medical device, digital health and diagnostics companies who are developing and selling their medical technology in the USA. Rowinski Group has offices in Silicon Valley – San Francisco Bay area and Chicago, Minneapolis, and Raleigh.

Rowinski Group has two core service offerings; securing codes and reimbursement on behalf of companies and applying healthcare payer data analytics to help companies solve business issues such as responding to questions from the FDA and Medicare, sales forecasting, Key Opinion Leader (KOL) identification etc.

Through these service offerings Rowinski Group help U.S. and international companies build their U.S. market share for the medical technology they are developing and selling. For more information visit https://reimbursement.consulting or contact Daniel Zimmerman d.zimmerman@reimbursement.consulting.